Futures
Access hundreds of perpetual contracts
TradFi
Gold
One platform for global traditional assets
Options
Hot
Trade European-style vanilla options
Unified Account
Maximize your capital efficiency
Demo Trading
Introduction to Futures Trading
Learn the basics of futures trading
Futures Events
Join events to earn rewards
Demo Trading
Use virtual funds to practice risk-free trading
Launch
CandyDrop
Collect candies to earn airdrops
Launchpool
Quick staking, earn potential new tokens
HODLer Airdrop
Hold GT and get massive airdrops for free
Launchpad
Be early to the next big token project
Alpha Points
Trade on-chain assets and earn airdrops
Futures Points
Earn futures points and claim airdrop rewards
More
BioNTech SE (BNTX) stock price plunges over 20%, hitting a 52-week low near $80.46. Previously, the company reported an adjusted net loss of $0.33 per share for Q4 2025, below expectations, and its revenue forecast for 2026 was weak, only between €2 billion and €2.3 billion. To make matters worse, co-founder and key executive, CEO Ugur Sahin, and Chief Marketing Officer Özlem Türeci announced plans to leave by the end of 2026, sparking serious concerns about the company's strategic direction as it transitions from COVID-19 vaccine revenue.